Long-acting amylin receptor agonists and uses thereof

MYPI2025008253A0Undetermined Publication Date: 2022-09-03ELI LILLY & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025008253
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-03-03
Filing Date
2022-03-02
Publication Date
2022-09-03
Patent Text Reader

Abstract

The present disclosure relates to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity and / or chronic weight management, dyslipidemia and / or NASH. The disclosure relates to compounds that agonize the amylin receptor and can lower food intake, body weight, glucose and / or triglycerides, so can be used to treat diabetes, obesity, and / or dyslipidemia. The present disclosure also includes pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions.
Need to check novelty before this filing date? Find Prior Art